Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: A systematic review

European Journal of Heart Failure

Volumn 8, Issue 4, 2006, Pages 390-399

  Latour Pérez, Jaime ^a,b   Coves Orts, Francisco Javier ^a   Abad Terrado, Carmen ^a   Abraira, Víctor ^c,d   Zamora, Javier ^c,d  

^a Hospital General Universitari d'Elx Elx   (Spain)

^b UNIVERSITY OF ALICANTE   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Heart failure; Meta analysis; Natriuretic peptides; ROC curve; Sensitivity and specificity; Systematic review

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA BASE; DIAGNOSTIC ACCURACY; EMBASE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MEDICAL RESEARCH; MEDLINE; METHODOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLICATION; ROC CURVE; SENSITIVITY AND SPECIFICITY; STANDARD; SYSTEMATIC REVIEW;

CARDIAC OUTPUT, LOW; HUMANS; NATRIURETIC PEPTIDE, BRAIN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33744935242     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.10.004     Document Type: Article

References (71)

1. Remes J., Miettinen H., Reunanen A., and Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12 (1991) 315-321
2. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
3. Nielsen O.W., McDonagh T.A., Robb S.D., and Dargie H.J. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol 41 (2003) 113-120
4. Sim V., Hampton D., Phillips C., Lo S.N., Vasishta S., Davies J., et al. The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction - cost-effectiveness in relation to open access echocardiography. Fam Pract 20 (2003) 570-574
5. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
6. McCullough P.A., Nowak R.M., McCord J., Hollander J.E., Herrmann H.C., Steg P.G., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 (2002) 416-422
7. Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
8. Doust J.A., Glasziou P.P., Pietrzak E., and Dobson A.J. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164 (2004) 1978-1984
9. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., and Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3 (2003) 25
10. Lijmer J.G., Mol B.W., Heisterkamp S., Bonsel G.J., Prins M.H., van der Meulen J.H., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282 (1999) 1061-1066
11. Egger M., Davey S.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
12. Littenberg B., and Moses L.E. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 13 (1993) 313-321
13. Deeks D.J. Systematic reviews of evaluations of diagnostic and screening tests. In: Egger M., Davey S.G., and Altman D.G. (Eds). Systematic reviews in health care. Metaanalysis in context. 2nd edition ed. (2001), BMJ Publishing Group, London 248-282
14. Deville W.L., Buntinx F., Bouter L.M., Montori V.M., de Vet H.C., van der Windt D.A., et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2 (2002) 9
15. Zamora J., Muriel A., and Abraira V. Meta-DiSc for windows: a software package for the meta-analysis of diagnostic and screening tests. XI Cochrane Colloquium Barcelona (2003 (Octubre))
16. Bettencourt P., Ferreira A., Pardal-Oliveira N., Pereira M., Queiros C., Araujo V., et al. Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction. Clin Cardiol 23 (2000) 921-927
17. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study. Am J Med 116 (2004) 509-516
18. Choy A.M., Darbar D., Lang C.C., Pringle T.H., McNeill G.P., Kennedy N.S., et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 72 (1994) 16-22
19. Clerico A., Iervasi G., Del Chicca M.G., Emdin M., Maffei S., Nannipieri M., et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 21 (1998) 170-179
20. Cowie M.R., Struthers A.D., Wood D.A., Coats A.J., Thompson S.G., Poole-Wilson P.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1349-1353
21. Daggubati S., Parks J.R., Overton R.M., Cintron G., Schocken D.D., and Vesely D.L. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res 36 (1997) 246-255
22. Dao Q., Krishnaswamy P., Kazanegra R., Harrison A., Amirnovin R., Lenert L., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37 (2001) 379-385
23. Davidson N.C., Naas A.A., Hanson J.K., Kennedy N.S., Coutie W.J., and Struthers A.D. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 77 (1996) 828-831
24. Davis M., Espiner E., Richards G., Billings J., Town I., Neill A., et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343 (1994) 440-444
25. Dokainish H., Zoghbi W.A., Lakkis N.M., Al Bakshy F., Dhir M., Quinones M.A., et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109 (2004) 2432-2439
26. Dokainish H., Zoghbi W.A., Lakkis N.M., Quinones M.A., and Nagueh S.F. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 93 (2004) 1130-1135
27. Epshteyn V., Morrison K., Krishnaswamy P., Kazanegra R., Clopton P., Mudaliar S., et al. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 26 (2003) 2081-2087
28. Fleischer D., Espiner E.A., Yandle T.G., Livesey J.H., Billings J., Town I., et al. Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea. N Z Med J 110 (1997) 71-74
29. Friedl W., Mair J., Thomas S., Pichler M., and Puschendorf B. Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 76 (1996) 129-136
30. Hammerer-Lercher A., Neubauer E., Muller S., Pachinger O., Puschendorf B., and Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 310 (2001) 193-197
31. Hutcheon S.D., Gillespie N.D., Struthers A.D., and McMurdo M.E. B-type natriuretic peptide in the diagnosis of cardiac disease in elderly day hospital patients. Age Ageing 31 (2002) 295-301
32. Joung B.Y., Park B.E., Kim D.S., Hong B.K., Kim D.Y., Cho Y.H., et al. B-type natriuretic peptide predicts clinical presentations and ventricular overloading in patients with heart failure. Yonsei Med J 44 (2003) 623-634
33. Jourdain P., Funck F., Canault E., Bellorini M., Deschamps P., Duval G., et al. Value of type B natriuretic peptide in the emergency management of patients with suspected cardiac failure. Report of 125 cases. Arch Mal Coeur Vaiss 95 (2002) 763-767
34. Knudsen C.W., Riis J.S., Finsen A.V., Eikvar L., Muller C., Westheim A., et al. Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoea: effect of age and gender. Eur J Heart Fail 6 (2004) 55-62
35. Koon J., Hope J., and Garcia A. A rapid bedside test for brain natriuretic peptide accurately predicts cardiac function in patients referred for echocardiography. J Am Coll Cardiol 35 (2000) 419A (Suppl)
36. Krishnaswamy P., Lubien E., Clopton P., Koon J., Kazanegra R., Wanner E., et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 111 (2001) 274-279
37. Lainchbury J.G., Campbell E., Frampton C.M., Yandle T.G., Nicholls M.G., and Richards A.M. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42 (2003) 728-735
38. Landray M.J., Lehman R., and Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ 320 (2000) 985-986
39. Logeart D., Gambert A., Beyne P., Guiti C., Geyer C., Bourgoin P., et al. Brain natriuretic peptide (BNP) in heart failure: relationship with left ventricular filling and exercise tolerance. Ann Cardiol Angeiol (Paris) 48 (1999) 523-528
40. Logeart D., Saudubray C., Beyne P., Thabut G., Ennezat P.V., Chavelas C., et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 40 (2002) 1794-1800
41. Luchner A., Burnett Jr. J.C., Jougasaki M., Hense H.W., Heid I.M., Muders F., et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 18 (2000) 1121-1128
42. Maisel A.S., Koon J., Krishnaswamy P., Kazenegra R., Clopton P., Gardetto N., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141 (2001) 367-374
43. Mallamaci F., Zoccali C., Tripepi G., Benedetto F.A., Parlongo S., Cataliotti A., et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59 (2001) 1559-1566
44. McClure S.J., Caruana L., Davie A.P., Goldthorp S., and McMurray J.J. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ 317 (1998) 516-519
45. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
46. McGeoch G., Lainchbury J., Town G.I., Toop L., Espiner E., and Richards A.M. Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Fail 4 (2002) 479-483
47. McLean A.S., Tang B., Nalos M., Huang S.J., and Stewart D.E. Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 31 (2003) 21-27
48. Misuraca G., Serafini O., Caporale R., Battista F., and Plastina F. Diagnosis of heart failure in general medicine: role of cerebral natriuretic peptide. Results of a pilot study of a population sample from Calabria. Ital Heart J 3 (2002) 928-932
49. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., and Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 (2002) 202-209
50. Motwani J.G., McAlpine H., Kennedy N., and Struthers A.D. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 341 (1993) 1109-1113
51. Muders F., Kromer E.P., Griese D.P., Pfeifer M., Hense H.W., Riegger G.A., et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 134 (1997) 442-449
52. Osca J., Quesada A., Arnau M.A., Osa A., Hervas I., Almenar L., et al. Brain natriuretic peptide. Diagnostic value in heart failure. Rev Esp Cardiol 55 (2002) 7-15
53. Pfister R., Scholz M., Wielckens K., Erdmann E., and Schneider C.A. The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients. Dtsch Med Wochenschr 127 (2002) 2605-2609
54. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 109 (2004) 3176-3181
55. Richards A.M., Nicholls M.G., Yandle T.G., Ikram H., Espiner E.A., Turner J.G., et al., The Christchurch Cardioendocrine Research Group. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 81 (1999) 114-120
56. Smith H., Pickering R.M., Struthers A., Simpson I., and Mant D. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ 320 (2000) 906-908
57. Sparrow N., Adlam D., Cowley A., and Hampton J.R. The diagnosis of heart failure in general practice: implications for the UK National Service Framework. Eur J Heart Fail 5 (2003) 349-354
58. Tjeerdsma G., de Boer R.A., Boomsma F., van den Berg M.P., Pinto Y.M., and van Veldhuisen D.J. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure. Int J Cardiol 86 (2002) 143-149
59. Valli N., Georges A., Corcuff J.B., Barat J.L., and Bordenave L. Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data. Clin Chim Acta 306 (2001) 19-26
60. Vasan R.S., Benjamin E.J., Larson M.G., Leip E.P., Wang T.J., Wilson P.W., et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288 (2002) 1252-1259
61. Villacorta H., Duarte A., Duarte N.M., Carrano A., Mesquita E.T., Dohmann H.J., et al. The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq Bras Cardiol 79 (2002) 569-8
62. Waku S., Iida N., and Ishihara T. Significance of brain natriuretic peptide measurement as a diagnostic indicator of cardiac function. Methods Inf Med 39 (2000) 249-253
63. Wieczorek S.J., Wu A.H., Christenson R., Krishnaswamy P., Gottlieb S., Rosano T., et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 144 (2002) 834-839
64. Yamamoto K., Burnett Jr. J.C., Jougasaki M., Nishimura R.A., Bailey K.R., Saito Y., et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28 (1996) 988-994
65. Yamamoto K., Burnett J.C., Bermudez Jr. E.A., Jougasaki M., Bailey K.R., and Redfield M.M. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail 6 (2000) 194-200
66. Remme W.J., and Swedberg K. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4 (2002) 11-22
67. The National Institute of Clinical Excellence. Management of chronic heart failure in adults in primary and secondary care. NICE Guideline 5 (2003 (July))
68. Mak G.S., DeMaria A., Clopton P., and Maisel A.S. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J 148 (2004) 895-902
69. Maisel A.S., McCord J., Nowak R.M., Hollander J.E., Wu A.H., Duc P., et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41 (2003) 2010-2017
70. Sterne J.A., Egger M., and Smith G.D. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 323 (2001) 101-105
71. Song F., Khan K.S., Dinnes J., and Sutton A.J. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31 (2002) 88-95